CHF

L'Oreal (Paris:OR)

L'Oréal, the world leader in cosmetics, stands out for its presence in all market segments, from hair care to luxury perfumes and anti-aging care. The French group is benefiting particularly from the aging of the world's population and is maintaining stable growth, despite a currently high valuation.

L'Oreal (Paris:OR) Read More »

BiC (Paris:BB)

BIC, famous for its pens, razors and lighters, stands out for its cost management strategy and its majority in-house production. The French company, which has also launched into mobile phones with the BIC Phone, has a good return-to-risk ratio and could represent an interesting investment opportunity despite some volatility.

BiC (Paris:BB) Read More »

Abbott Laboratories (NYSE:ABT)

Abbott Laboratories, an American pharmaceutical company founded in Chicago, split in 2013 into two separate entities: Abbott (ABT) specializing in nutrition and medical devices, and AbbVie (ABBV) focused on drugs. This historic company, characterized by its stability and regular dividend growth, continues to demonstrate its strength in the market with controlled volatility and an effective concentration strategy.

Abbott Laboratories (NYSE:ABT) Read More »

Performance 2012

The performance of the CHF portfolio was positive in 2012, reaching +10.17%, thanks to a strong first half. However, its defensive vocation translates into an annual return since launch of +7.76%, and a performance below that of the market during the bullish phases.

Performance 2012 Read More »